Dolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients

Published:2014-10 Issue:5 Volume:15 Page:199-208
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Curtis L.,Nichols G.,Stainsby C.,Lim J.,Aylott A.,Wynne B.,Clark A.,Bloch M,Maechler G.,Martin-Carpenter L..,Raffi F.,Min S.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1310/hct1505-199

Reference8 articles.

1. Dolutegravir in antiretroviral-naive adults with HIV-1

2. Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

3. Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

4. Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

5. Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver function tests, CD4+ counts, and viral load among people living with HIV on dolutegravir compared to efavirenz-based cART; a comparative cross-sectional study;Heliyon;2024-06

2. Dolutegravir and the management of HIV/AIDS in the South African adult population;SA Pharmaceutical Journal;2024-04

3. Efficacy, safety, and tolerability of dolutegravir-based ART regimen in Durban, South Africa: a cohort study;BMC Infectious Diseases;2024-03-21

4. Virgin Coconut Oil Protects Against Dolutegravir-induced Toxicity in Wistar Albino Rats;2024-03-18

5. Dolutegravir‐induced acquired sideroblastic anemia in a HIV positive patient: A challenging hematologic complication;Clinical Case Reports;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3